Journal Scope
Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.
Info. and Statistics
- Acceptance rate 12.39%
- Frequency monthly
- Impact factor (2018) 7.199
- Indexed by Medline/PubMed, PubMed Central, European PubMed, Scopus, EBSCO
- Launch date 1952
- Lead times Average time to first decision: 14 days
- ISSN Print: 0012-1797; Online: 1939-327X
Diabetes Online
In order to make original research available faster than traditional print publishing allows, articles accepted for publication in Diabetes are published online ahead of print 3–5 days after acceptance. Online Ahead of Print articles are citable by DOI. DOIs for ADA journals articles begin with 10.2337, followed by the article number assigned when the manuscript was submitted online via the manuscript submission system (e.g., 10.2337/db16-1234).
Free Content. The full text of all articles (html view) is freely accessible online on the Diabetes website 6 months after the print publication date, and PDFs become freely accessible 12 months after the print publication date. In addition, the following are freely available immediately upon publication:
- ADA-authored articles, including the annual Scientific Sessions Abstract supplement
- Commentaries
- Symposia articles
- Invited articles
- Online-only letters
- In This Issue article summaries
- Supplemental material
- Errata and retractions
The access icons found to the left of the article title on table of contents and search result views will indicate whether the article is freely available. An unlocked lock or green check mark mean the paper is available, and a green lock means it is currently accessible only with an active subscription.
Privacy Policy. For information about ADA's information practices and the choices you can make about the way your information is collected and used by ADA, please refer to ADA’s Privacy Policy.
Copyright and Public Access
Copyright. The American Diabetes Association holds copyright on all content published in ADA journals, unless otherwise noted. Readers may use the content as long as the work is properly cited and linked to the original source, the use is educational and not for profit, and the work is not altered. Articles may not be included without ADA permission in educational materials that are sold to students or used in courses for which tuition or other fees are charged.
Postprints. Authors are permitted to submit the final, accepted version of their manuscript to their funding body or institution for inclusion in their funding body or institution's database, archive, or repository, or to post the final, accepted version on their personal website. These manuscripts may be made freely accessible to the public upon acceptance. For details see: Copyright Notice and Public Access Policy.
Public Access. As a courtesy to authors, the final print versions of articles funded by NIH will be deposited in PubMed Central (PMC) at no additional cost. In compliance with NIH’s policy, these articles will appear on PMC 12 months after print publication in Diabetes Care, Diabetes, Clinical Diabetes, or Diabetes Spectrum. All articles, regardless of funding body, are delivered to PubMed for inclusion in the PubMed index.
